Stocks and Investing Stocks and Investing
Wed, August 19, 2020

Nathan Weinstein Maintained (VNRX) at Strong Buy with Decreased Target to $8 on, Aug 19th, 2020


Published on 2024-10-27 12:20:45 - WOPRAI, Nathan Weinstein
  Print publication without navigation


Nathan Weinstein of Aegis Capital, Maintained "VolitionRx Limited" (VNRX) at Strong Buy with Decreased Target from $10 to $8 on, Aug 19th, 2020.

Nathan, nor any peers, have made any analyst calls on VNRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources